ArticlePharmaceutical research2026
Mechanistic Insights into Poloxamer 188-Mediated Stabilization of AAV8 Capsids Using Coarse-Grained Molecular Dynamics.
Article in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAggregation of adeno-associated virus (AAV) during manufacturing and storage remains a challenge in gene therapy formulation. This study evaluates how varying Poloxamer188 (P188) concentrations affect the structural stability and aggregation behavior of two full AAV8 capsids.
methodsCoarse-grained molecular dynamics simulations of AAV8 capsids with P188 were performed for 4000 ns at 300 K. Center-of-mass (COM) separation, residue-level contacts, surface coverage, van der Waals interactions, radius of gyration (Rg), relative shape anisotropy (k
resultsPersistent capsid association was not observed in systems containing 10 or 24 P188 molecules (0.15% and 0.35% w/v), whereas systems containing 2 or 5 P188 molecules (0.03% and 0.07% w/v) showed delayed association relative to the surfactant-free system. Capsid surface coverage increased with P188 loading. Polyethylene oxide (EO) segments associated with the capsid surface early and persistently, followed by gradual polypropylene oxide (PO) engagement, indicating a preferential/sequential interaction mechanism. Higher P188 loadings showed negligible van der Waals attraction, consistent with steric shielding. Chain-resolved Rg and k
conclusionsThese findings provide mechanistic insight into the stabilizing effect of P188 on AAV via concentration-dependent surface coverage and steric hindrance that minimize capsid-capsid interactions associated with aggregation. The reported concentrations are nominal finite-box values defined by discrete P188 molecule counts and represent comparative simulation conditions rather than experimentally derived formulation thresholds. These findings provide a molecular basis for understanding P188-mediated AAV stabilization and for guiding formulation optimization.
Indexed as
Identifiers
42773382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.